Sino Medical: Announcement on the Share Repurchase Plan via Centralized Bidding

NightAirdropper · 2026-02-27T22:17:31+00:00

Sino Medical plans to repurchase some A-shares through centralized bidding, with the repurchase amount ranging from 15 million to 30 million yuan. The funding will mainly come from a dedicated loan from Shanghai Pudong Development Bank and its own funds. The repurchase period is from March 13, 2026, to March 12, 2027.

NightAirdropper

2026-02-27 22:17:31

Abstract generation in progress

Securities Daily News reported that on February 25, Sinocare announced that, after considering the company’s financial situation and future profitability, the company plans to repurchase some of its outstanding A-shares through centralized bidding on the Shanghai Stock Exchange trading system. The repurchased shares will be used for employee stock ownership plans or equity incentives.
Repurchase amount: not less than RMB 15 million (inclusive) and not more than RMB 30 million (inclusive), with a special bank repurchase loan not exceeding RMB 27 million (inclusive).
Funding sources for the repurchase: a dedicated stock repurchase loan provided by Tianjin Branch of Shanghai Pudong Development Bank (referred to as “SPDB”) and the company’s own funds, with the loan amount not exceeding 90% of the total repurchase transaction.
Repurchase price: no more than RMB 35.10 per share (inclusive).
Repurchase period: within 12 months from the date the company’s shareholders’ meeting approves the repurchase plan (from March 13, 2026, to March 12, 2027).

(Edited by Ren Shibi)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes